(株)中京医薬品の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4558/E03289 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2023/12/22 | 日証協 | 488,800株 | -3.07% | 10,500株 | +9999.99% | 997,859株 | -0.21% | 55,400株 | +477.08% |
| 2023/12/15 | 日証協 | 504,300株 | -0.02% | 100株 | -99.73% | 999,959株 | +0.26% | 9,600株 | -67.89% |
| 2023/12/08 | 日証協 | 504,400株 | +4.82% | 37,200株 | 0% | 997,410株 | +2.26% | 29,900株 | +35.91% |
| 2023/12/01 | 日証協 | 481,200株 | -1.76% | 0株 | -100% | 975,410株 | -0.7% | 22,000株 | -60.64% |
| 2023/11/24 | 日証協 | 489,800株 | +1.83% | 14,200株 | +4633.33% | 982,310株 | +0.55% | 55,901株 | +146.25% |
| 2023/11/17 | 日証協 | 481,000株 | -0.04% | 300株 | 0% | 976,909株 | +0.48% | 22,701株 | +254.65% |
| 2023/11/10 | 日証協 | 481,200株 | -0.25% | 0株 | -100% | 972,208株 | -0.18% | 6,401株 | +48.86% |
| 2023/11/02 | 日証協 | 482,400株 | +1.56% | 7,600株 | +1420% | 974,007株 | -0.42% | 4,300株 | -44.16% |
| 2023/10/27 | 日証協 | 475,000株 | -0.21% | 500株 | -83.33% | 978,106株 | +0.53% | 7,701株 | -31.86% |
| 2023/10/20 | 日証協 | 476,000株 | -2.36% | 3,000株 | 0% | 972,906株 | -0.16% | 11,301株 | -3.41% |
| 2023/10/13 | 日証協 | 487,500株 | -0.04% | 0株 | -100% | 974,505株 | +0.01% | 11,700株 | -25.79% |
| 2023/10/06 | 日証協 | 487,700株 | +0.37% | 13,400株 | -47.24% | 974,405株 | +95.61% | 15,766株 | -96.74% |
| 2023/09/29 | 日証協 | 485,900株 | -3.69% | 25,400株 | -2.68% | 498,124株 | -49.74% | 484,316株 | +2715.79% |
| 2023/09/22 | 日証協 | 504,500株 | +0.44% | 26,100株 | -28.49% | 991,004株 | -2.26% | 17,200株 | -48.35% |
| 2023/09/15 | 日証協 | 502,300株 | +2.2% | 36,500株 | +272.45% | 1,013,904株 | -0.51% | 33,304株 | +129.68% |
| 2023/09/08 | 日証協 | 491,500株 | +1.32% | 9,800株 | +716.67% | 1,019,100株 | +1.79% | 14,500株 | -70.94% |
| 2023/09/01 | 日証協 | 485,100株 | -2.1% | 1,200株 | +71.43% | 1,001,201株 | +0.46% | 49,900株 | +239.46% |
| 2023/08/25 | 日証協 | 495,500株 | -1.53% | 700株 | -98.8% | 996,601株 | -0.98% | 14,700株 | -60.16% |
| 2023/08/18 | 日証協 | 503,200株 | +6.34% | 58,200株 | +449.06% | 1,006,501株 | +3.06% | 36,900株 | +107.3% |
※株式分割は考慮していませんのでご注意ください。
Page Top